Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-22-048378
Filing Date
2022-04-21
Accepted
2022-04-21 16:05:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A tm2212074-3_s3a.htm S-3/A 656253
2 GRAPHIC lg_adaptimmune-4c.jpg GRAPHIC 59488
  Complete submission text file 0001104659-22-048378.txt   739478
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-264208 | Film No.: 22841452
SIC: 2836 Biological Products, (No Diagnostic Substances)